Garuda is proud to recognize this coming Sunday, April 7 as World Health Day. This year’s theme is, 'My health, my right’ – designed to call attention to the need for universal access to the services, education and information that support human health. At Garuda, we aim to contribute to the advancement of health for all by developing our off-the-shelf blood stem cell therapies to potentially provide curative treatments for more than 120 diseases.
Garuda Therapeutics’ Post
More Relevant Posts
-
Wednesday, June 19th is World Sickle Cell Awareness Day – dedicated to raising awareness of #SickleCellDisease and how it impacts patients, families and care partners. At Garuda, we’re working to advance our off-the-shelf blood #stemcell therapies to potentially treat a broad range of severe and life-threatening diseases, including sickle cell disease. Learn more about our breakthrough approach: bit.ly/3NrS9t0
-
-
April is #NationalCancerControlMonth – dedicated to promoting #cancer prevention, early detection and elevating the voices of patients, survivors and care partners. #GarudaTx is proud to recognize National Cancer Control Month and to be advancing our off-the-shelf blood #stemcell therapies which have the potential to provide cancer patients with life-changing treatment options.
-
-
Garuda is proud to recognize March 8 as #InternationalWomensDay. In honor of this day and #NationalWomensHistoryMonth in March, we express our gratitude to the women on the Garuda team and in the broader biotech industry for their role in advancing innovation in the #lifesciences. #IWD2024
-
-
March 4-8 is National Aplastic Anemia & MDS (myelodysplastic syndromes) Awareness Week. Aplastic anemia, or bone marrow failure, is a serious and potentially fatal blood condition where the body stops producing enough new blood cells to function properly. At Garuda, we’re committed to advancing our off-the-shelf, blood stem cell therapies with the potential to offer a curative treatment to patients with hematological diseases such as Aplastic Anemia and MDS. Get involved and learn more from the Aplastic Anemia & MDS International Foundation: bit.ly/3UZHDP2
-
-
March 1 is #EmployeeAppreciationDay! Made up of science-driven individuals with a passion for serving patients, the #GarudaTx team is making our mission to build the future of blood #stemcell therapies a reality. Today and every day, we are incredibly grateful for the Garuda team and their dedication to delivering transformative medicines to patients.
-
-
Garuda is proud to recognize February 29 as #RareDiseaseDay – a day dedicated to raising awareness and inspiring action for the 300 million people living with a #RareDisease worldwide. At Garuda, we’re developing off-the-shelf, durable blood stem cell therapies with the potential to provide curative treatment options to millions of patients with rare diseases. Learn more about our approach: bit.ly/3NrS9t0
-
-
What does 2024 hold for #biopharma? Garuda Therapeutics’ Co-founder, President & CEO Dhvanit Shah expects an increased appetite for off-the-shelf blood stem cell therapies due to their ability to bypass many challenges associated with current treatment options. Check it out: bit.ly/49BZlfA
-
-
Congratulations to Rob Labriola, Executive Director of Regulatory Operations at Garuda, who has been selected to serve on the Drug Information Association (DIA) conference planning committee for DIA’s Regulatory Submissions, Information, and Document Management (RSIDM) Forum, taking place February 12-14, 2024 in North Bethesda, MD. Rob will also lead the Forum track on Building and Sustaining Successful RSIDM Foundations. Register for this can’t miss event which will feature over 90 diverse speakers from regulatory, industry and academia: bit.ly/48PqknX
-
